COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection

In March 2020, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was declared a global pandemic by the World Health Organization (WHO). The clinical course of the disease is unpredictable but may lead to severe acute respiratory infection (SARI) and pneumonia leading to acute respiratory dist...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceuticals (Basel)
Main Authors: Kotfis, Katarzyna, Lechowicz, Kacper, Drożdżal, Sylwester, Niedźwiedzka-Rystwej, Paulina, Wojdacz, Tomasz K., Grywalska, Ewelina, Biernawska, Jowita, Wiśniewska, Magda, Parczewski, Miłosz
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7830835/
https://ncbi.nlm.nih.gov/pubmed/33477294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14010071
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados